Influenza Therapeutics

1. Coherent Market Insights The CDC recommends four FDA-approved influenza therapeutics (antiviral drugs). In the United States, flu season occurs in the fall and winter. Generally, strains of influenza tend to last from two to last from two to four weeks before fading out. During this period, most people will have no problem contracting influenza. Most flu viruses are strain specific, which means that if a person has one type of influenza, they are less likely to pass it on to others. How are flu symptoms classified as flu? Flu seasons last about 3 weeks, starting around October and lasting until February. Symptoms will start to appear in early spring, but they can continue to be a part of spring even after the peak of the season ends. Symptoms typically include cough, fever, chills, sore throat, headache, swollen glands, diarrhea, vomiting, irritability, fatigue, loss of appetite, dizziness, twitching, ringing in the ears, etc. Each of these symptoms last for a varying amount of time based on the severity of the infection and the influenza therapeutics adopted for treatment. Although seasonal, the threat of getting flu remains, so do ways to protect yourself. One approach in influenza therapeutics is vaccination. Flu vaccines help prevent the spread of influenza, as well as other viruses like measles and rubella. Flu vaccination is recommended for anyone who may be susceptible, such as children, pregnant women, those on immune-suppressing medications, or those taking medications that affect their immune system, such as cancer treatments. Read More : https://bit.ly/2SpHw0A Coherent Market Insights